Results 161 to 170 of about 605,792 (294)

Heterogeneity in hepatic transport of somatostatin analog octapeptides [PDF]

, 1994
Gert Fricker
openalex   +1 more source

Comparing Somatostatin Analogs in the Treatment of Advanced Gastroenteropancreatic Neuroendocrine Tumors. [PDF]

Oncology, 2022
Allaw MB, Switchenko JM, Khalil L, Wu C, Alese OB, Akce M, Draper A, Jones AT, El-Rayes B, Shaib W.   +9 more
europepmc   +1 more source

Long-Term Efficacy and Safety of Combined Treatment of Somatostatin Analogs and Pegvisomant in Acromegaly [PDF]

, 2007
Sebastian Neggers, Maarten O. van Aken, J. A. M. J. L. Janssen, Richard A. Feelders, Wouter W. de Herder, Aart‐Jan van der Lely   +5 more
openalex   +1 more source

A Real-World Observational Study of the Use and Associated Costs of Treating Neuroendocrine Tumors With Somatostatin Analogs in Canada. [PDF]

Pancreas, 2022
Cheung WY, LaForty C, Liovas A, McKechnie H, Loree JM.   +4 more
europepmc   +1 more source

Effect of Somatostatin Analog on Postprandial Satiation in Obesity [PDF]

, 2005
Filippo Cremonini, Michael Camilleri, Jonathan Gonenne, Debra Stephens, LaVonne Oenning, Kari Baxter, Amy E. Foxx–Orenstein, Duane D. Burton   +7 more
openalex   +1 more source

Efficacy of cabergoline add-on therapy in patients with acromegaly resistance to somatostatin analogs treatment and the review of literature. [PDF]

Arch Endocrinol Metab, 2022
Kizilgul M, Duger H, Nasiroglu NI, Sencar E, Hepsen S, Akhanli P, Berker D, Cakal E, Bostan H, Ucan B.   +9 more
europepmc   +1 more source

Complete remission of recurrent multiple insulin-producing neuroendocrine tumors of the pancreas with somatostatin analogs: a case report and literature review. [PDF]

Discov Oncol, 2022
Tartaglia A, Busonero G, Gagliardi L, Boddi V, Pieri F, Nizzoli M.   +5 more
europepmc   +1 more source

Somatostatin analogs for gastric carcinoids: For many, but not all

, 2015
Sara Massironi, Alessandra Zilli, Dario Conte   +2 more
openalex   +2 more sources

Synchronous AML and pancreatic neuroendocrine neoplasm, both successfully treated with somatostatin analogs and decitabine. [PDF]

Endocr Oncol, 2022
Ehsanullah S, Trikalinos NA.
europepmc   +1 more source

T2-weighted MRI signal predicts hormone and tumor responses to somatostatin analogs in acromegaly.

Endocrine-Related Cancer, 2016
I. Potorac, P. Pétrossians, A. Daly, O. Alexopoulou, S. Borot, M. Sahnoun-Fathallah, F. Castinetti, F. Devuyst, M. Jaffrain-Rea, C. Briet, F. Luca, M. Lapoirie, F. Zoicas, I. Simoneau, A. Diallo, A. Muhammad, F. Keleştimur, E. Nazzari, R. Centeno, S. Webb, M. Nunes, V. Hána, V. Pascal-Vigneron, Irena Ilovayskaya, F. Nasybullina, S. Achir, D. Ferone, S. Neggers, B. Delemer, J. Petit, C. Schöfl, G. Raverot, B. Goichot, P. Rodien, B. Corvilain, T. Brue, F. Schillo, L. Tshibanda, D. Maiter, J. Bonneville, A. Beckers   +40 more
semanticscholar   +1 more source